Wall Street Analysts Think Orchestra BioMed Holdings, Inc. (OBIO) Could Surge 72.41%: Read This Before Placing a Bet
HC Wainwright & Co. Maintains Buy on Orchestra BioMed Hldgs, Raises Price Target to $12
BTIG Maintains Buy on Orchestra BioMed Hldgs, Raises Price Target to $12
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Misses Revenue Estimates
Orchestra BioMed Hldgs Q3 EPS $(0.30) Beats $(0.40) Estimate, Sales $91.000K Miss $106.000K Estimate
Orchestra BioMed Announces Pricing of Public Offering
Orchestra BioMed Announces Proposed Public Offering
Orchestra BioMed Commences Common Stock Offering; Terms Not Disclosed
Orchestra BioMed Has A Clearer Trial Timeline But A Demanding Valuation
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates
Orchestra BioMed Hldgs Q2 EPS $(0.38) Misses $(0.37) Estimate, Sales $88.000K Miss $121.400K Estimate
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock
B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.